medigraphic.com
ISSN 1561-3011 (Electronic)

2011, Number 3

<< Back Next >>

Rev Cubana Invest Bioméd 2011; 30 (3)

Incidence of myocardial acute infarction

Ortega TYY, Armas RNB, de la Noval GR, Castillo AI, Suárez MR, Dueñas HAF

Language: Spanish
References: 26
Page: 345-353
PDF size: 422.64 Kb.


ABSTRACT

INTRODUCTION: The myocardial acute infarction is one the first death causes in the world and in Cuba; in past years its distribution is unknown in our country.
OBJECTIVE: To describe the morbidity of myocardial acute infarction in Cuba: 1999-2008.
METHODS: A descriptive and cross-sectional study was conducted. Universe included persons aged e» 25 during 1999-2008 in whose population were identified the subjects suffered myocardial acute infarction. Data were collected from registry of National Management of Statistics and the incidence rates were estimated. Variables used were: occurrence place; provinces: Pinar del Río, Provincia Habana, Ciudad de La Habana, Matanzas, Cienfuegos, Villa Clara, Sancti Spiritus, Ciego de Avila, Camagüey, Las Tunas, Holguín, Granma, Santiago de Cuba, Guantánamo, especial municipality of Isla de la Juventud.
RESULTS: Incidence rates in our country remained around the 1,9 by 1000 inhabitants as average during the study period. Ciudad de La Habana was the province of greater incidence in the first and second five-year period with rates of 3.0 and 2.6 by 1000 inhabitants, respectively.
CONCLUSIONS: The incidence due to myocardial acute infarction in Cuba during 1999-2008, remained without significant variations. Thr risk of suffering such disease for the population aged over 25, was high and constant during decade. The provinces with higher incidence were Ciudad de La Habana, Camagüey, Sancti Spiritus and province of Habana.


REFERENCES

  1. WHO. World Health Organization. [consultado16 Ene 2009]. Disponible en: http://www.who.int/cardiovascular_diseases/en/

  2. Gaziano JM. Repercusión global de las enfermedades cardiovasculares. En: Rodríguez PL, ed. Braunwald's Heart Disease: A textbook of cardiovascular Medicine. 7ma ed. Madrid: ELSEVIER, 2006; p. 11-29.

  3. Murray CJ, López A. Alternative projections of mortality and disability by cause 1990- 2020: global burden of disease study. Lancet. 1997;347:1498-1504.

  4. Life tables for WHO Member States. Geneva, World Health Organization. 2006. [consultado16 Ene 2009]. Disponible en: http://www.who.int/whosis/database/life_tables/life_tables.cfm

  5. Omran AR. The epidemiologic transition: a theory of the epidemiology of population change. En: Rodriguez PL, ed. Braunwald's Heart Disease: A textbook of cardiovascular Medicine. 7ma ed. Madrid: ELSEVIER, 2006. p. 7-10.

  6. Olshansky SJ, Ault AB, The fourth stage of the epidemiologic transition: The age of delayed degenerative diseases. En: Rodriguez PL, ed. Braunwald's Heart Disease: A textbook of cardiovascular Medicine. 7ma Ed. Madrid: ELSEVIER, 2006. p. 31-40.

  7. Davies Ruth A, Smeeth L, Marjatta DE: Contribution of changes in incidence and mortality to trends in the prevalence of coronary heart disease in the UK: 19962005. European Heart Journal. 2007;28:2142-7.

  8. Marrugat J, Elosua R, Covas MI, Fitó M, Schröder H, Masià R, et al. Registre Gironí del cor. Estudi REGICOR a les comarques de Girona. Barcelona: Departament de Salut. 2008. [consultado 18 Jun 2009]. Disponible en: http://www.gencat.cat/salut/depsan/units/sanitat/pdf/regicorcat.pdf

  9. Medrano AJ, Boix MR, Cerrato CE, Ramírez SM. Incidencia y prevalencia de cardiopatía isquémica y enfermedad cerebrovascular en España: Revisión sistemática de la literatura. Rev Esp Salud Pública. 2006;80(1):3-7.

  10. American Heart Association. Heart Disease and Stroke Statistics 2010. Update: A Report From the American Heart Association. Dallas. Circulation [serie en Internet] 2010. [consultado 3 Jun 2011 ];121:46-215. Disponible en: http://circ.ahajournals.org/cgi/content/full/121/7/e46

  11. Stamler J, Greenland P, Deloria M, Neaton J, Dyer A, Garside D, et al. Major Risk Factors as Antecedents of Fatal and Nonfatal Coronary Heart Disease Events. JAMA. 2003;290:891-7.

  12. Hurst´s the Heart. Arteries and Veins. 10th ed. New York: Mc Graw-Hill; 2001. p. 3-7.

  13. Ministerio de Salud Pública. Anuario Estadístico 2002. La Habana: MINSAP; 2003.

  14. Peñalver Hernández E, Dueñas Herrera A, Dieste Sánchez W, Nordet Cardona P. Influencia de los factores de riesgo coronario en la incidencia de cardiopatía isquémica. Rev Cubana Med Gen Integr. 1999;15(4):368-71.

  15. Ordúñez-García P, Espinosa-Brito A, Cooper R. Community-Based Hypertension Prevention and Control: Lessons learned from CARMEN initiative in Cienfuegos, Cuba. ProCor. World Hypertension Day. 2005. [consultado18 Jun 2009]. Disponible en: http://www.procor.org/discussion/display

  16. Giraldo G. Three-Pronged Innovation to Improve Care for Acute Myocardial Infarction Patients in Cuba. MEDICC Review. 2010;12:11-6.

  17. Tunstall-Pedoe H, Vanuzzo D, Hobbs M, Mahonen M, Cepaitis Z, Kuulasmaa K, et al. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations. Lancet. 2000;355:688-700.

  18. Yusuf S, Srinath R, Ôunpuu S, Anand S. Global Burden of Cardiovascular Diseases Part I: General Considerations, the Epidemiologic Transition, Risk Factors, and Impact of Urbanization. Circulation. 2001;104:2746-53.

  19. MINSAP. Anuario Estadístico de Salud 2008. No. 37. [consultado18 Jun 2009]. Disponible en: http://www.sld.cu/galerias/pdf/sitios/dne/anuario_2008_3e.pdf

  20. Banegas JR, Villar F, Graciani A, Rodríguez-Artalejo F. Epidemiología de lasenfermedades cardiovasculares en España. Rev Esp Cardiol. Supl. 2006;6:G3-12.

  21. Gil M, Martí H, Elosúa R, Grau M. Análisis de la tendencia en la letalidad, incidencia y mortalidad por infarto de miocardio en Girona entre 1990 y 1999. Rev Esp Cardiol. 2007;60(4):349-56.

  22. Marrugat J, Elousa R, Martí H. Epidemiología de la cardiopatía isquémica en España: estimación del número de casos y las tendencias entre 1997 y 2005. Rev Esp Cardiol. 2002;55:337-46.

  23. Instituto Nacional de Estadística. Defunciones según la causa de muerte 2002. Madrid: Instituto Nacional de Estadística; 2005.

  24. Muller-Nordhorn J, Brinting S, Roll S. An update on regional variation in cardiovascular Mortality within Europe. Eur Heart J. 2008;29:1316-26.

  25. Cardiovascular Disease in England: Opportunities and Challenges Over the Next Ten Years. British Heart Foundation. April 2008. [consultado 16 Jun 2009]). Disponible en: http://www.cardiovascularcoalition.org.uk

  26. Instituto Nacional de Higiene, Epidemiología y Microbiología. II Encuesta Nacional de Factores de Riesgo de Enfermedades Crónicas no transmisibles en Cuba. Informe de trabajo. La Habana: INHEM (CU); 2002.




2020     |     www.medigraphic.com